01 1Divis Laboratories
01 1NAPROXEN SODIUM USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-08-07
Pay. Date : 2013-07-26
DMF Number : 13867
Submission : 1998-11-27
Status : Active
Type : II
20
Divis Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is NAPROXEN SODIUM USP, with a corresponding US DMF Number 13867.
Remarkably, this DMF maintains an Active status since its submission on November 27, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 07, 2013, and payment made on July 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
LOOKING FOR A SUPPLIER?
Market Place
